2Malloy MJ, Kane JP. A risk factor for atherosclerosis : triglyceride - rich lipoproteins[J]. Adv. Intern. Med, 2001,47, 111 -136.
3Krauss RM. Triglycerides and atherogenic lipoproteins:rationale for lipid management [ J ]. Am J Med, 1998,105 (S) :58 - 62.
4Shoulders CC, Harry PJ, Lagrost L, et al. Variation at the APOAI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII [ J ]. Atheroselerosis, 1991,87 : 239 - 247.
5Groenendijk M, Cantor RM, De Bruin, et al. The apoAl - CIII - AIV gene cluster[ J]. Atherosclerosis,2001,157 : 1 - 11.
6Pennacchio LA, Olivier M, Hubacek JA, et al. An appolipoprotein influencing triglyceride in humans and mice revealed by comparative sequencing. [J] Science, 2001,94 : 169-173.
7Vander Vliet HN, Sananels MG, Leegwater AC, et al. Apolipoprotein AV:a novel apolipoprotein associated with an nearly phase of liver regeneration. [J] J Biol Chem, 2001, 276(48) : 44512- 44520.
8Aouizerat BE, Kulkarni MA, Heilbom D, et al. Genetic analysis of a polymorphism in the human apoA - V gene lipid : effect on plasma lipids[J]. J Lipid Res, 2003,44:1167 - 1173.
9Talmud PJ, Martin S, Taskinen MR, et al. APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study[J]. J Lipid Res,2004, 45 : 750 - 756.
10Endo BH, Yanagi J,Araki C, et al. Association found between the promoter region polymorphism the apolipoprotein A - V gene and the serum triglyceride level in Japanese schoolchildren [ J ]. Hum, Genet, 2002, 111:570 -572.
3Hokanson JE, Austin MA. Plasma triglyeeride level is a risk factor for cardiovascular disease independent of high density lipoprotein choles- terol level : a meta-analysis of population-based prospective studies. J Cardiovasc Risk, 1996,3 : 213-219.
5Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotien in- fluencing triglycerides in humans and mice revealed by comparative sequencing. Science, 2001,294 : 169-173.
6Yin RX, Li YY, Wu JZ, et al. Interactions between the apolipopro- tein al/c3/a5 haplotypes and alcohol consumption on serum lipid lev- els. Alcohol Clin Exp Res, 2013,37 :234-243.
7Yin RX, Li YY, Lai CQ. Apolipoprotein AI/C3/A5 haplotypes and serum lipid levels. Lipids Health Dis,2011,10: 140.
8Guardiola M, Ribaha J, G6mez-Coronado D, et al. The apolipopro- tein A5 (APOA5) gene predisposes Caucasian children to elevated triglycerides and vitamin E (Four Provinces Study). Atherosclerosis, 2010,212 : 543-547.
9Kim JY, Kim OY, Paik JK, et al. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels. J Clin Lipidol, 2013,7:94-101.
10Sharma V, Forte TM, Ryan RO. Influence of apolipoprotein A-V on the metabolic fate of triacylglycerol. Curt Opin Lipidol,2013,24: 153-159.
